作者: G Ganesh Konduri , Alfonso Solimano , Gregory M Sokol , Joel Singer , Richard A Ehrenkranz
关键词: Anesthesia 、 Medicine 、 Respiratory failure 、 Extracorporeal membrane oxygenation 、 Multicenter trial 、 Oxygenation 、 Oxygenation index 、 Respiratory disease 、 Pulmonary hypertension 、 Randomized controlled trial
摘要: Objective. Inhaled nitric oxide (iNO) reduces the use of extracorporeal membrane oxygenation (ECMO)/incidence death in term and near-term neonates with severe hypoxic respiratory failure. We conducted a randomized, double masked, multicenter trial to determine whether administration iNO earlier failure results additional reduction incidence these outcomes. Methods. Neonates who were born at ≥34 weeks’ gestation enrolled when they required assisted ventilation had an index (OI) ≥15 Results. The enrollment was halted after 75% target sample size reached because decreasing availability eligible patients. 150 infants given early 149 control similar baseline characteristics. Arterial oxygen tension increased by >20 mm Hg 73% 37% study gas initiation. Control received standard deteriorated OI >40 more often than iNO. (early iNO, 6.7% vs control, 9.4%), ECMO (10.7% 12.1%), their combined (16.7% 19.5%) both groups. Conclusion. improves but does not reduce ECMO/mortality initiated 15 25 compared initiation >25